(1 - 29 von 37
)
Nivolumab und Cabozantinib: Zwei neue Wirkstoffe bei ...
www.aerzteblatt.de
Sep 28, · Cabozantinib konnte anders als Nivolumab das progressionsfreie Überleben von 3,8 auf 7,4 Monate verlängern, wie Toni Choueiri vom Dana-Farber Cancer Institute aus Boston und Mitarbeiter im …
Ipsen Announces Data Presentations of Cabozantinib (Cabometyx),...
www.finanznachrichten.de
Dr. Toni Choueiri, Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Session: Presidential session 3 Oral presentation Monday, October
Coronavirus study: Cancer treatment not major COVID-19 risk ...www.usatoday.com › story › news › health ›
eu.usatoday.com
... may face, and to help guide treatment, said co-author Toni Choueiri, a genitourinary oncologist at the Dana-Farber Cancer Institute in Boston.
How kidney cancer affects the risks of coronavirus - Kidney ...www.kidneycancer.org › stories
www.kidneycancer.org
Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute/Brigham and Women's Hospital in Boston, ...
sortiert nach Relevanz / Datum